We have applied short and long TCR-CD3 stimulation of CD47-sufficient and CD47-deficient CD8+ T cells in vitro and tested CD8+ T cell physiology utilizing in vivo viral infection as well as tumor implantation models in CD47-sufficient and CD47-deficient mice. This evidence concerns the gene CD47 and neoplasm.